X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (111009) 111009
Book Review (22503) 22503
Publication (7882) 7882
Newspaper Article (3515) 3515
Newsletter (1229) 1229
Book Chapter (610) 610
Magazine Article (597) 597
Conference Proceeding (434) 434
Trade Publication Article (283) 283
Book / eBook (258) 258
Dissertation (101) 101
Web Resource (100) 100
Transcript (39) 39
Reference (21) 21
Data Set (15) 15
Report (15) 15
Paper (10) 10
Government Document (7) 7
Presentation (5) 5
Journal / eJournal (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (92748) 92748
humans (73282) 73282
male (45040) 45040
female (38797) 38797
insulin (38583) 38583
animals (34642) 34642
diabetes (29081) 29081
endocrinology & metabolism (25070) 25070
middle aged (22987) 22987
adult (22826) 22826
insulin resistance (22782) 22782
insulin - therapeutic use (22584) 22584
hypoglycemic agents - therapeutic use (18126) 18126
glucose (17775) 17775
insulin-resistance (16887) 16887
mice (14378) 14378
obesity (14149) 14149
aged (13907) 13907
rats (13701) 13701
type 2 diabetes (13247) 13247
diabetes mellitus, type 2 - drug therapy (13052) 13052
blood glucose - metabolism (12984) 12984
diabetes mellitus (11981) 11981
pharmacology & pharmacy (11890) 11890
abridged index medicus (10990) 10990
risk factors (10989) 10989
research (10732) 10732
insulin - blood (10053) 10053
metabolism (9927) 9927
analysis (9523) 9523
health aspects (8610) 8610
physiological aspects (8510) 8510
care and treatment (8316) 8316
adolescent (8173) 8173
insulin - metabolism (7954) 7954
rodents (7933) 7933
blood glucose - analysis (7449) 7449
metabolic syndrome (7443) 7443
diabetes mellitus, type 1 - drug therapy (7432) 7432
proteins (7302) 7302
hyperglycemia (7266) 7266
insulin - administration & dosage (7237) 7237
inflammation (7034) 7034
oxidative stress (6764) 6764
treatment outcome (6723) 6723
medicine (6631) 6631
mellitus (6535) 6535
diabetes mellitus - drug therapy (6398) 6398
diabetes mellitus, type 2 - blood (6254) 6254
child (6070) 6070
dextrose (5935) 5935
expression (5882) 5882
cell biology (5852) 5852
research article (5820) 5820
biochemistry & molecular biology (5748) 5748
gene expression (5694) 5694
time factors (5655) 5655
medicine & public health (5648) 5648
internal medicine (5602) 5602
article (5456) 5456
hypoglycemic agents - administration & dosage (5396) 5396
medicine, general & internal (5330) 5330
body mass index (5287) 5287
diabetes therapy (5263) 5263
multidisciplinary sciences (5209) 5209
studies (5168) 5168
medicine, research & experimental (5076) 5076
physiology (5064) 5064
therapy (5055) 5055
liver (4935) 4935
risk (4934) 4934
diet (4850) 4850
glycemic control (4812) 4812
hypoglycemia (4711) 4711
glucose metabolism (4678) 4678
mortality (4545) 4545
blood glucose - drug effects (4533) 4533
glucose - metabolism (4427) 4427
disease (4395) 4395
mice, inbred c57bl (4347) 4347
metformin (4334) 4334
type 1 diabetes (4312) 4312
body weight (4309) 4309
glucose tolerance test (4292) 4292
hypertension (4273) 4273
drug therapy (4264) 4264
lipids (4246) 4246
signal transduction (4226) 4226
insulin secretion (4195) 4195
hypoglycemic agents - pharmacology (4136) 4136
science (4128) 4128
insulin sensitivity (4079) 4079
nutrition & dietetics (4052) 4052
medical research (3958) 3958
diabetes mellitus, type 2 - metabolism (3951) 3951
apoptosis (3935) 3935
patients (3851) 3851
diabetes mellitus, type 2 - complications (3809) 3809
pregnancy (3762) 3762
cancer (3759) 3759
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (143) 143
Online Resources - Online (57) 57
Collection Dvlpm't (Acquisitions) - Vendor file (25) 25
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
UofT at Mississauga - Stacks (5) 5
St. Michael's Hospital - Stacks (4) 4
Scarborough Hospital - Birchmount (3) 3
Thomas Fisher Rare Book - Rare Book (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
University College (Laidlaw) - Stacks (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Engineering & Comp. Sci. - Material is damaged (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
OISE - Theses (1) 1
Providence Healthcare - Reference (1) 1
Robarts - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
University Archives - Archives (1) 1
UofT at Mississauga - Not Returned (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (111122) 111122
German (1496) 1496
French (1150) 1150
Russian (675) 675
Japanese (607) 607
Spanish (518) 518
Italian (411) 411
Chinese (352) 352
Polish (286) 286
Czech (134) 134
Portuguese (129) 129
Dutch (113) 113
Hungarian (96) 96
Danish (71) 71
Swedish (68) 68
Finnish (48) 48
Bulgarian (41) 41
Romanian (40) 40
Norwegian (33) 33
Hebrew (32) 32
Serbian (27) 27
Turkish (19) 19
Ukrainian (19) 19
Croatian (18) 18
Korean (17) 17
Slovak (16) 16
Lithuanian (8) 8
Arabic (6) 6
Afrikaans (2) 2
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Indonesian (1) 1
Persian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, ISBN 1934844632, xi, 228
Book
Web Resource
2007, Endocrinology and metabolism clinics of North America, Volume 36, suppl. 1., 52
Book
Diabetes technology & therapeutics, ISSN 1520-9156, 1999
Journal
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, pp. e77296 - e77296
In the present study, we investigated the therapeutic potential of a selective S1P1 receptor modulator, ponesimod, to protect and reverse autoimmune diabetes... 
Glucose-6-Phosphatase - genetics | Recurrence | Receptors, Lysosphingolipid - antagonists & inhibitors | Lymph Nodes - pathology | Spleen - immunology | Spleen - drug effects | Adoptive Transfer | CD3 Complex - genetics | T-Lymphocytes - drug effects | Receptors, Lysosphingolipid - genetics | Lymph Nodes - drug effects | B-Lymphocytes - pathology | Diabetes Mellitus, Type 1 - immunology | T-Lymphocytes - pathology | Spleen - pathology | Gene Expression | Drug Administration Schedule | Administration, Oral | Diabetes Mellitus, Type 1 - pathology | Self Tolerance | Diabetes Mellitus, Type 1 - genetics | Glucose-6-Phosphatase - immunology | Lymph Nodes - immunology | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemic Agents - pharmacology | Antibodies - pharmacology | B-Lymphocytes - drug effects | Receptors, Lysosphingolipid - immunology | Animals | B-Lymphocytes - immunology | Glucose-6-Phosphatase - antagonists & inhibitors | CD3 Complex - immunology | Lymphocyte Count | Mice, Inbred NOD | T-Lymphocytes - immunology | Mice | Thiazoles - pharmacology | Cell proliferation | Multiple sclerosis | Transplants & implants | Disease | Leukocyte migration | Migration | Transgenic | Lymphocytes T | Arthritis | Adoptive transfer | Lymph nodes | Restoration | Lymphocytes | Rodents | Peripheral blood | Remission | Catalysis | Pancreas | Spleen | Immunoglobulins | Medical treatment | Diabetes mellitus | CD3 antigen | Insulin | Immunological tolerance | Beta cells | Lymphocytes B | Diabetes | Islets of Langerhans | Autoimmune diseases | Glucose-6-phosphatase | Cell migration | Pharmaceuticals | Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 2009, Volume 32, Issue 5, pp. 762 - 768
0.0001). beta-Cell function measures returned to pretreatment values in both groups after a 4-week off-drug period. A1C and body weight rose to pretreatment... 
NON-INFERIORITY | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | BASAL INSULIN | GLUCOSE | ENDOCRINOLOGY & METABOLISM | SECRETION | MELLITUS | TWICE-DAILY EXENATIDE | Metformin - therapeutic use | C-Peptide - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Exenatide | Female | Insulin - analogs & derivatives | Insulin Secretion | Body Mass Index | Hypoglycemic Agents - therapeutic use | Insulin-Secreting Cells - physiology | Insulin, Long-Acting | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Insulin-Secreting Cells - drug effects | Insulin Glargine | Arginine - pharmacology | Venoms - therapeutic use | Kinetics | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Peptides - therapeutic use | Index Medicus | Original Research | Hemoglobin A | Insulin/analogs & derivatives/secretion/therapeutic use | Blood Glucose/metabolism | Type 2/blood/drug therapy/physiopathology | MEDICIN OCH HÄLSOVETENSKAP | Diabetes Mellitus | Insulin-Secreting Cells/drug effects/physiology | Venoms/therapeutic use | Metformin/therapeutic use | Glycosylated/metabolism | Peptides/therapeutic use | Arginine/pharmacology | Hypoglycemic Agents/therapeutic use | C-Peptide/blood | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
Current Alzheimer Research, ISSN 1567-2050, 04/2007, Volume 4, Issue 2, pp. 159 - 164
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide Current treatment for... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Index Medicus | Abridged Index Medicus | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
2015, Frontiers in Diabetes, ISBN 331802337X, Volume 24
Web Resource
ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 01/2011, Volume 154, Issue 2, pp. 103 - 103
Background: Insulin replacement in diabetes often requires prandial intervention to reach hemoglobin A(1c) (HbA(1c)) targets. Objective: To test whether... 
NPH INSULIN | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | ORAL-THERAPY | ADD-ON | GLUCOSE-LOWERING DRUGS | COMBINATION THERAPY | PARALLEL-GROUP | NAIVE PEOPLE | OPEN-LABEL | TO-TARGET TRIAL | Metformin - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Body Weight - drug effects | Male | Thiazolidinediones - administration & dosage | Peptides - administration & dosage | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Sensitivity and Specificity | Venoms - administration & dosage | Female | Insulin - analogs & derivatives | Metformin - administration & dosage | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Insulin, Long-Acting | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Insulin - administration & dosage | Diabetes Mellitus, Type 2 - blood | Insulin Glargine | Venoms - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - therapeutic use | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Glycosylated hemoglobin | Physiological aspects | Research | Diagnosis | Drug therapy | Injections | Side effects | Clinical trials | Diabetes | Hypoglycemia | Insulin | Weight | Index Medicus | Abridged Index Medicus
Journal Article
Regulatory Peptides, ISSN 0167-0115, 2008, Volume 149, Issue 1, pp. 79 - 83
The nose provides an effective way for delivering neuropeptides to the central nervous system, bypassing the blood-brain barrier and avoiding systemic side... 
Body weight regulation | Obesity | Neuropeptides | Intranasal administration | Cognition | Central nervous system | ALZHEIMER-DISEASE | PHYSIOLOGY | cognition | OBESE ZUCKER RATS | INSULIN-SECRETION | neuropeptides | CEREBROSPINAL-FLUID | BLOOD-PRESSURE | central nervous system | BODY-WEIGHT | intranasal administration | body weight regulation | CENTRAL-NERVOUS-SYSTEM | MELANIN-CONCENTRATING HORMONE | REDUCES FOOD-INTAKE | CENTRAL LEPTIN | obesity | Central Nervous System - metabolism | Humans | Adrenocorticotropic Hormone - pharmacology | Body Weight - drug effects | Melanocyte-Stimulating Hormones - pharmacology | Cognition Disorders - metabolism | Male | Peptide Fragments - pharmacology | Adrenocorticotropic Hormone - administration & dosage | Metabolic Diseases - therapy | Hypoglycemic Agents - administration & dosage | Neuropeptides - pharmacology | Receptors, Melanocortin - agonists | Female | Hypoglycemic Agents - therapeutic use | Satiety Response - drug effects | Insulin - pharmacology | Neuropeptides - administration & dosage | Adrenocorticotropic Hormone - therapeutic use | Melanocyte-Stimulating Hormones - administration & dosage | Peptide Fragments - administration & dosage | Nootropic Agents - therapeutic use | Insulin - administration & dosage | Administration, Intranasal | Hypoglycemic Agents - pharmacology | Neuropeptides - therapeutic use | Obesity - metabolism | Melanocyte-Stimulating Hormones - therapeutic use | Metabolic Diseases - metabolism | Signal Transduction - drug effects | Nootropic Agents - administration & dosage | Obesity - therapy | Peptide Fragments - therapeutic use | Cognition Disorders - therapy | Body Weight - physiology | Adipose Tissue - drug effects | Insulin - therapeutic use | Nootropic Agents - pharmacology | Index Medicus
Journal Article
Circulation: Heart Failure, ISSN 1941-3289, 01/2016, Volume 9, Issue 1
Background The prevalence of pre-diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known. We... 
heart failure | Clinical trial | diabetes mellitus | prognosis | treatment outcome | clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | TOLERANCE | HEMOGLOBIN A(1C) | HOSPITALIZATION | INHIBITION | A1C | INSULIN-RESISTANCE | GLUCOSE | DYSFUNCTION | OUTCOMES | Diabetes Mellitus - blood | Single-Blind Method | Prevalence | Prospective Studies | Ventricular Function, Left | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Male | Heart Failure - blood | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Heart Failure - diagnosis | Diabetes Mellitus - diagnosis | Diabetes Mellitus - mortality | Prediabetic State - epidemiology | Heart Failure - mortality | Prediabetic State - blood | Risk Assessment | Comorbidity | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Heart Failure - drug therapy | Prediabetic State - mortality | Prediabetic State - diagnosis | Stroke Volume | Disease-Free Survival | Diabetes Mellitus - epidemiology | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Blood Glucose - metabolism | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | Index Medicus | 10093 | 10150 | 10094 | Original | glucose | hospitalization | inhibition | Klinisk medicin | dysfunction | Clinical Medicine | a1c | insulin-resistance | hemoglobin a(1c) | Cardiovascular System & Cardiology | predictor | cardiovascular risk | tolerance
Journal Article